Writing Group for the Bypass Angioplasty Revascularisation Investigation (BARI) Investigators. Fivdie-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease: a multicenter randomized trial. JAMA 1997; 277(9): 715-721.
Cox J.L. A perspective of postoperative atrial fibrillation in cardiac operations. Ann. Thorac. Surg. 1993; 56(3): 405-409.
Herlitz J. Death, mode of death, morbidity, and rehospitalization after coronary artery bypass grafting in relation to occurrence of and time since a previous myocardial infarction. Thorac.Cardiovasc. Surg. 1997; 45 (3):109-113.
Frost L. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int. J. Cardiol. 1992; 36 (3): 253-261.
Serrano Junior C.V. Prognostic significance of right ventricular dysfunction in patients with acute inferior myocardial infarction and right ventricular involvement. Clin.Cardiol. 1995; 18(4): 199-205.
Руководство Национальной академии клинической биохимии по лабораторной медицинской практике использования биохимических маркеров при ОКС и СН. Лаб. диагностика 2008;1:13-32.
Carrier M. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann. Thorac. Surg. 2000; 69 (2): 435-440.
Galvani M., Ferrini D., Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur. J. HeartFailure 2004; 6 (3): 327-333.